Company / SG&A per Share
BioNexus Gene Lab Corp SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.85
FY2025
5-year range
$0.01 / $0.85
FY2021-FY2025
Trend
+723.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +724% YoY in FY2025, a notable deviation from the 6-year average annual change of +403%.
Based on SEC 10-K filings.
0.85 in FY2025 with a 5-year CAGR of +131.1%.
Increased from $0.17 to $0.85 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +339.0%
- 5-Year CAGR
- +131.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 723.7% year-over-year.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.85 | +723.7% |
| FY2024 | $0.10 | -38.5% |
| FY2023 | $0.17 | +1570.6% |
| FY2022 | $0.01 | +35.4% |
| FY2021 | $0.01 | -42.5% |
| FY2020 | $0.01 | +171.5% |
| FY2019 | $0.00 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026